Tokyo Tape
Sign in
← Cyfuse Biomedical

Annual report

4892.TEDINET S100T55F
Period2023-01-01 → 2023-12-31
Filed2024-03-27
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 75
MetricValuePeriodScopeSource row
Revenue¥61m2023-01-01 → 2023-12-31StandaloneNet sales
Revenue¥374m2022-01-01 → 2022-12-31StandaloneNet sales
Revenue¥708m2021-01-01 → 2021-12-31dStandaloneNet sales (5-year summary)
Revenue¥137m2020-01-01 → 2020-12-31dStandaloneNet sales (5-year summary)
Revenue¥122m2019-01-01 → 2019-12-31dStandaloneNet sales (5-year summary)
Operating income−¥697m2023-01-01 → 2023-12-31StandaloneOperating income
Operating income−¥425m2022-01-01 → 2022-12-31StandaloneOperating income
Ordinary income−¥586m2023-01-01 → 2023-12-31StandaloneOrdinary income
Ordinary income−¥433m2022-01-01 → 2022-12-31StandaloneOrdinary income
Ordinary income¥145m2021-01-01 → 2021-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥327m2020-01-01 → 2020-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥369m2019-01-01 → 2019-12-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥586m2023-01-01 → 2023-12-31StandaloneIncome before income taxes
Profit before tax−¥472m2022-01-01 → 2022-12-31StandaloneIncome before income taxes
Net income−¥589m2023-01-01 → 2023-12-31StandaloneProfit loss
Net income−¥474m2022-01-01 → 2022-12-31StandaloneProfit loss
Net income¥143m2021-01-01 → 2021-12-31dStandaloneNet income loss (5-year summary)
Net income−¥330m2020-01-01 → 2020-12-31dStandaloneNet income loss (5-year summary)
Net income−¥372m2019-01-01 → 2019-12-31dStandaloneNet income loss (5-year summary)
Total assets¥4.2bnat 2023-12-31StandaloneAssets
Total assets¥4.8bnat 2022-12-31StandaloneAssets
Total assets¥2.6bnat 2021-12-31dStandaloneTotal assets (5-year summary)
Total assets¥2.2bnat 2020-12-31dStandaloneTotal assets (5-year summary)
Total assets¥2.0bnat 2019-12-31dStandaloneTotal assets (5-year summary)
Total liabilities¥1.0bnat 2023-12-31StandaloneLiabilities
Total liabilities¥1.0bnat 2022-12-31StandaloneLiabilities
Net assets / equity¥3.2bnat 2023-12-31StandaloneNet assets
Net assets / equity¥3.8bnat 2022-12-31StandaloneNet assets
Net assets / equity¥1.9bnat 2021-12-31dStandaloneNet assets
Net assets / equity¥1.5bnat 2020-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥1.8bnat 2019-12-31dStandaloneNet assets (5-year summary)
Cash and deposits¥3.9bnat 2023-12-31StandaloneCash and deposits
Cash and deposits¥4.4bnat 2022-12-31StandaloneCash and deposits
Cash & equivalents¥2.9bnat 2023-12-31StandaloneCash and cash equivalents
Cash & equivalents¥3.4bnat 2022-12-31StandaloneCash and cash equivalents
Cash & equivalents¥1.6bnat 2021-12-31dStandaloneCash and cash equivalents
Cash & equivalents¥1.3bnat 2020-12-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow−¥562m2023-01-01 → 2023-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥404m2022-01-01 → 2022-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow¥162m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥294m2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥19m2023-01-01 → 2023-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥431m2022-01-01 → 2022-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥51m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥264,0002020-01-01 → 2020-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥18m2023-01-01 → 2023-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥2.7bn2022-01-01 → 2022-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥229m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥489m2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-75.422023-01-01 → 2023-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-177.672022-01-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥285.532021-01-01 → 2021-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-658.342020-01-01 → 2020-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-371,133.372019-01-01 → 2019-12-31dStandaloneBasic earnings loss per share (5-year summary)
Net assets per share¥405.71at 2023-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥484.88at 2022-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥-5,183.91at 2021-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥-5,469.44at 2020-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥-2,405,548.48at 2019-12-31dStandaloneNet assets per share (5-year summary)
Equity ratio76.0%at 2023-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio78.3%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio71.8%at 2021-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio70.5%at 2020-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio87.2%at 2019-12-31dStandaloneEquity to asset ratio (5-year summary)
ROE8.3%2021-01-01 → 2021-12-31dStandaloneRate of return on equity (5-year summary)
Shares issued7,894,300at 2023-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued7,773,300at 2022-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued1,001at 2021-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued1,001at 2020-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued1,001at 2019-12-31dStandaloneTotal number of issued shares (5-year summary)
Employees21at 2023-12-31StandaloneNumber of employees
Employees21at 2022-12-31StandaloneNumber of employees
Employees22at 2021-12-31dStandaloneNumber of employees
Employees19at 2020-12-31dStandaloneNumber of employees
Employees19at 2019-12-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 817
ItemContextValueUnit
Research and development expenses sgaCurrentYearDuration_NonConsolidatedMember375584000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)有価証券報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2024-03-27
Fiscal year cover pageFilingDateInstant
Original text (Japanese)第14期(自　2023年１月１日　至　2023年12月31日)
Company name cover pageFilingDateInstant
Original text (Japanese)株式会社サイフューズ
Company name in english cover pageFilingDateInstantCyfuse Biomedical K.K.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役　　秋　枝　静　香
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都港区三田三丁目５番27号　住友不動産三田ツインビル西館
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)(03)6435－1885(代表)
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)取締役 ＣＦＯ 経営管理部長　　三　條　真　弘
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都港区三田三丁目５番27号　住友不動産三田ツインビル西館
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)(03)6435－1885(代表)
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)取締役 ＣＦＯ 経営管理部長　　三　條　真　弘
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE38156
Fund codeFilingDateInstant－
Security codeFilingDateInstant48920
Filer name in japaneseFilingDateInstant
Original text (Japanese)株式会社サイフューズ
Filer name in englishFilingDateInstantCyfuse Biomedical K.K.
Fund name in japaneseFilingDateInstant－
Fund name in englishFilingDateInstant－
Cabinet office ordinanceFilingDateInstant
Original text (Japanese)企業内容等の開示に関する内閣府令
Document typeFilingDateInstant
Original text (Japanese)第三号様式
Accounting standardsFilingDateInstantJapan GAAP
Whether consolidated financial statements are preparedFilingDateInstantfalse
Industry code when consolidated financial statements are prepared in accordance with industry specific regulationsFilingDateInstant－
Industry code when financial statements are prepared in accordance with industry specific regulationsFilingDateInstantcte
Current fiscal year start dateFilingDateInstant2023-01-01
Current period end dateFilingDateInstant2023-12-31
Type of current periodFilingDateInstantFY
Current fiscal year end dateFilingDateInstant2023-12-31
Previous fiscal year start dateFilingDateInstant2022-01-01
Comparative period end dateFilingDateInstant2022-12-31
Previous fiscal year end dateFilingDateInstant2022-12-31
Next fiscal year start dateFilingDateInstant－
End date of quarterly or semi annual period of next fiscal yearFilingDateInstant－
Amendment flagFilingDateInstantfalse
Identification of document subject to amendmentFilingDateInstant－
Report amendment flagFilingDateInstantfalse
Xbrl amendment flagFilingDateInstantfalse
Business results of reporting company (text)FilingDateInstantText · Plus
Company history (text)FilingDateInstantText · Plus
Description of business (text)FilingDateInstantText · Plus
Overview of affiliated entities (text)FilingDateInstantText · Plus
Information about employees (text)FilingDateInstantText · Plus
Business policy business environment issues to address etc (text)FilingDateInstantText · Plus
Strategy (text)FilingDateInstantText · Plus
Metrics and targets (text)FilingDateInstantText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2022-12-31pass
balance sheet identitynon_consolidated 2023-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2021-12-31pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2023-12-31pass
statement vs summary · operating cash flownon_consolidated 2022-01-01/2022-12-31pass
statement vs summary · operating cash flownon_consolidated 2023-01-01/2023-12-31pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-12-31pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-12-31pass
statement vs summary · total assetsnon_consolidated 2022-12-31pass
statement vs summary · total assetsnon_consolidated 2023-12-31pass